Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,284 across all filing types
Latest filing 2025-12-24 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
关于取得新兽药注册证书的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from 瑞普生物股份有限公司 regarding the approval of new veterinary drug registration certificates by the Ministry of Agriculture and Rural Affairs. It details the new products approved, their technical features, and the company's plans to apply for product approval numbers. The document is a regulatory announcement about product registration and approvals, not a financial report, earnings release, or management discussion. It does not contain financial data, management changes, or voting results. It is a formal regulatory announcement about new product registrations, fitting best under Regulatory Filings (RNS). The document length is short (1890 characters), and it is not announcing a report publication but a regulatory approval. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2025-12-24 Chinese
第六届董事会第一次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the first (extraordinary) meeting of the sixth board of directors of 瑞普生物股份有限公司. It details the election of the chairman, appointment of board committees, and hiring of senior management personnel. The document includes voting results and references to related announcements on official websites. It does not contain financial statements or detailed financial performance data. The content focuses on board and management changes, which fits the category of Board/Management Information (MANG). The document length is 2234 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the appropriate classification is MANG with high confidence.
2025-12-15 Chinese
关于董事会换届完成暨聘任高级管理人员及证券事务代表的公告
Board/Management Information Classification · 100% confidence The document is an announcement from 瑞普生物股份有限公司 regarding the completion of the board of directors' re-election and the appointment of senior management and securities affairs representatives. It details the composition of the new board, committee memberships, and biographies of the directors and senior management. There is no financial data, earnings information, or regulatory filings related to financial performance. The content focuses on changes in the company's board and senior management personnel. Therefore, this document fits the category of Board/Management Information (MANG). The document length is sufficient and contains detailed information about board and management changes, not just a brief announcement or certification, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA).
2025-12-15 Chinese
2025年第六次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2025 sixth extraordinary shareholders meeting of 瑞普生物股份有限公司. It includes voting results on board elections, amendments to company bylaws, and internal control system changes. The document also contains legal opinions confirming the validity of the meeting and voting procedures. There is no financial data or report content, but rather the official results of shareholder votes at a general meeting. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 2822 characters, which is consistent with a detailed voting results announcement rather than a full report or presentation.
2025-12-15 Chinese
北京市通商律师事务所关于瑞普生物股份有限公司2025年第六次临时股东会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a legal opinion letter from a law firm regarding the convening, attendance, voting procedures, and results of the 2025 sixth extraordinary shareholders' meeting of a company. It details the legality and validity of the meeting process, attendees, and resolutions passed, including election of board members and amendments to company bylaws. The document does not contain financial statements or performance data, nor is it a report or announcement of financial results. It is a legal opinion related to a shareholders' meeting and the voting outcomes. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of the shareholders' meeting.
2025-12-15 Chinese
对外担保管理制度（2025年11月）
Governance Information Classification · 95% confidence The document is titled '对外担保管理制度' which translates to 'External Guarantee Management System' and is issued by 瑞普生物股份有限公司 (Rip Bio Co., Ltd.). It details the company's internal policies and procedures regarding external guarantees, including definitions, approval processes, responsibilities, disclosure requirements, and risk management. The document references relevant laws and stock exchange rules, and it is a governance-related internal policy document rather than a financial report, announcement, or regulatory filing. It does not contain financial statements, earnings data, or voting results. It is a detailed governance framework document about the company's external guarantee management. Therefore, the most appropriate classification is Governance Information (CGR). The document length (7447 characters) and content confirm it is a full policy document, not a brief announcement or certification.
2025-11-28 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.